Inclusion Criteria:  Patients age 18 and above No reported systemic disease that would compromise healing, such as Diabetes with A1c level >7.0%, endocrine disorders, hypertension above Stage II based on AHA 2017, osteoporosis, or immunodeficiency Healthy periodontium or demonstrating stable periodontal condition following conventional periodontal therapy. Clinical indication for periodontal mucogingival surgery utilizing palatal graft harvest e.g., shallow palatal vaults classified by Reiser et al. (1996) the average distance as 7 mm from the CEJ of maxillary teeth to the neurovascular bundle No history of previous palatal harvesting  Exclusion Criteria:  Smoker Pregnancy [confirmed via patient self-identification]  Systemic condition requiring antibiotic prophylaxis prior to any invasive procedure. The list of such conditions includes:  Prosthetic cardiac valves, including transcatheter-implanted prostheses and homografts Prosthetic material used for cardiac valve repair, such as annuloplasty rings and chords. Previous infective endocarditis Unrepaired cyanotic congenital heart disease or repaired congenital heart disease, with residual shunts or valvular regurgitation at the site of or adjacent to the site of a prosthetic patch or prosthetic device. Cardiac transplant with valve regurgitation due to a structurally abnormal valve. Uncontrolled systemic disease e.g., Diabetes with A1c level > 7.0% endocrine disorders, hypertension above Stage II based on AHA 2017, osteoporosis, or immunodeficiency) Use of medications, such as Dilantin (aka Phenytoin), Cyclosporin, and Nifedipin, that would adversely affect periodontal tissues